Summary
The Conventional clinical recognition of vitamin E deficiency has depended on lowered tocopherol levels in plasma and/or on increased propensity for hemolysis as a result of increased susceptibility of red blood cells (RBC) to hydrogen per oxide (1) (2) (3) (4) or dialuric acid used in place of hydrogen peroxide on testing rats for vitamin E deficiency (5, 6) . It has, however, been repeatedly claimed that the relationship between hemolysis induced by hydrogen peroxide or dialuric acid and plasma tocopherol levels is occasionally variable (2, 7). The possible reason for this inconsistency may include the fact that hemolysis derives from decreased RBC plasma. This may be a reason for the persistence of plasma tocopherol even during depletion. We believe that the relation of the plasma to the RBC membranes resembles that of adipose tissue to the plasma, as reported by Bieri and Macklin , taking into account the insufficient ability of the plasma to supply the RBC membranes with a reserve of tocopherol in cases of deficiency . Furthermore, we also believe that in tocopherol deficiency RBC tocopherol levels, rather than plasma levels, reflect the immediate nutritional state of vitamin E , and that the ratio of RBC tocopherol to plasma tocopherol should not be considered constant. The wide individual differences in the ratio, as reported in our preceding paper (11, 13) , must therefore be tenable. Determination of RBC to copherol levels should thus precede that of plasma tocopherol levels in the management of pediatric patients deficient in tocopherol.
